The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Study critique · continued

Coming back to: A structured critique template this community uses posts 31–60

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

TV
t.vasquezTL4 Moderator11 Jun 2026#31
Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

25 likes 2mo
VB
va.baptistaTL2 Moderator13 Jun 2026#32

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

12 likes 1mo
CR
compounding_ruthTL4Pharmacist14 Jun 2026#33

Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters.

1 like 1mo
NL
n.laurentTL2 Moderator15 Jun 2026#34
c.niemel, post #27: post #26 is right about the mechanism and I think understates the practical bit. Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for. Go to post

Picking up post #31: that is the part I would want checked first.

Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.

0 likes in reply to #27 1mo
IT
impurity_tableTL3Analytical chemist16 Jun 2026#35

Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is more idiosyncratic. That does not make it wrong but it is worth noticing.

0 likes 1mo
HD
h.delgadoTL2 Moderator18 Jun 2026 · edited#36

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

17 likes 1mo
BV
bias_varianceTL4Biostatistician19 Jun 2026#37

I read post #35 twice before replying, because I had assumed the opposite.

When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works.

4 likes 1mo
JM
j.moreauTL2 Moderator20 Jun 2026#38
n.laurent, post #34: Picking up post #31: that is the part I would want checked first. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence. Go to post

This follows post #35 rather than contradicting it.

Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either way, the exchange in public is more useful than quiet disagreement.

0 likes in reply to #34 1mo
AS
a.silvaTL2 Moderator21 Jun 2026#39

Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question.

0 likes 1mo
OC
o.cousineauTL3Regular23 Jun 2026#40

post #39 answers the question as asked. The question underneath it is different.

Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not how you use the evidence. The point estimate and the precision both matter.

24 likes 1mo
K
KAnderssonTL3Regular24 Jun 2026#41

post #40 answers the question as asked. The question underneath it is different.

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

0 likes 1mo
EF
e.ferreiraTL3Regular25 Jun 2026#42

On post #38 — agreed on the reasoning, with one qualification.

Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for.

1 like 1mo
TT
titrate_traceTL1Member26 Jun 2026 · edited#43
j.dahlberg, post #8: I read post #6 twice before replying, because I had assumed the opposite. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is more idiosyncratic. That does not make it wrong but it is worth noticing. Go to post

Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters.

6 likes in reply to #8 1mo
RB
r.bakkenTL2 Moderator27 Jun 2026#44

What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample size" alone is weak. "Small sample size for a rare outcome, so the confidence interval is wide" is stronger.

15 likes 30d
BW
bac_waterTL2Regular29 Jun 2026#45

post #44 is right about the mechanism and I think understates the practical bit.

Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question. Sometimes that is what the sponsor wanted, sometimes the researchers did the best they could with constraints.

0 likes 29d
SZ
s.zamoraTL2 Moderator30 Jun 2026#46
a.salcedo, post #4: Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question. Go to post

Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is more idiosyncratic. That does not make it wrong but it is worth noticing.

2 likes in reply to #4 28d
DS
d.szymanskiTL3Wiki editor1 Jul 2026#47

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

9 likes 27d
EN
e.ndiayeTL2 Moderator2 Jul 2026#48

I read post #46 twice before replying, because I had assumed the opposite.

When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works.

21 likes 26d
EF
e.ferreiraTL3Regular3 Jul 2026#49

Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not how you use the evidence. The point estimate and the precision both matter.

0 likes 24d
AJ
a.jansenTL2 Moderator5 Jul 2026 · edited#50
t.wojcik, post #9: post #8 answers the question as asked. The question underneath it is different. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism but requires specificity about which real people and why the difference matters. Go to post

Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question.

5 likes in reply to #9 23d
W
WickramasingheTL2Member6 Jul 2026#51

I read post #49 twice before replying, because I had assumed the opposite.

Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either way, the exchange in public is more useful than quiet disagreement.

28 likes 22d
DN
d.ndiayeTL27 Jul 2026#52
LA
l.aaltonenTL3Regular8 Jul 2026 · edited#53

When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works.

5 likes 20d
PO
p.onwukaTL2 Moderator9 Jul 2026#54

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

0 likes 19d
HN
h.nicolaidesTL3Regular10 Jul 2026#55
a.silva, post #39: Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished negative trials is a fair critical question. Go to post

Coming back to post #53, because the follow-up matters more than the original answer.

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

0 likes in reply to #39 17d
IG
in.guerreroTL2 Moderator12 Jul 2026#56
n.nakamura, post #28: Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound. Go to post

Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown confounders, though known confounders can be adjusted for.

20 likes in reply to #28 16d
EL
endpoint_lineTL3Regular13 Jul 2026#57

Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative statistical analysis might bias toward null.

8 likes 15d
ID
i.dumitruTL2 Moderator14 Jul 2026#58

post #57 answers the question as asked. The question underneath it is different.

Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and secondary analyses are weaker evidence.

2 likes 14d
R
RidgewayTL3Regular15 Jul 2026#59
e.ndiaye, post #48: I read post #46 twice before replying, because I had assumed the opposite. When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you originally thought. That is not a failure — it is how discussion works. Go to post

Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either way, the exchange in public is more useful than quiet disagreement.

0 likes in reply to #48 13d
SD
s.demirTL2 Moderator16 Jul 2026#60

Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is more idiosyncratic. That does not make it wrong but it is worth noticing.

27 likes 12d